Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.86
Delayed Data
As of 4:00pm ET
 +0.12 / +3.21%
Today’s Change
3.15
Today|||52-Week Range
9.19
-6.54%
Year-to-Date

Today’s Trading

Previous close3.74
Today’s open3.74
Day’s range3.73 - 3.89
Volume1,301,725
Average volume (3 months)1,878,083
Market cap$511.5M
Dividend yield--
Data as of 4:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-54.22%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.07-0.40%
VSARVersartis Inc+0.10+0.51%
SGYPSynergy Pharmaceutic...-0.01-0.37%
INSYINSYS Therapeutics I...-0.08-0.88%
Data as of 4:00pm ET, 09/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts